KYMR
Kymera Therapeutics, Inc.
Key figures
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $102M | +2.9% |
| Gross profit | $0 | — |
| Operating income | −$405M | — |
| Net income | −$349M | — |
| EPS | −$3.62 | — |
| Free cash flow | −$289M | — |
Kymera Therapeutics, Inc.
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $102M | +2.9% |
| Gross profit | $0 | — |
| Operating income | −$405M | — |
| Net income | −$349M | — |
| EPS | −$3.62 | — |
| Free cash flow | −$289M | — |